Understanding the extent to which the CCR5Δ32 variant influences the health of different populations is critical since it indicates which individuals and ethnic groups are more likely to benefit from therapies focused on modulating CCR5 in the context of cancer, infections, and inflammatory diseases. Here, CCR5 is linked to cancer.